Hetastarch

FDA Drug Profile

Drug Details

Generic Name
Hetastarch
Brand Names
N/A
Application Number
Sponsor
Fresenius Kabi AUT GmbH
NDC Codes
1
Dosage Forms
POWDER
Routes
N/A
Active Ingredients
HETASTARCH

Indications and Usage

1 INDICATIONS AND USAGE 6% Hetastarch in 0.9% Sodium Chloride Injection is indicated in the treatment of hypovolemia when plasma volume expansion is desired. It is not a substitute for blood or plasma. The adjunctive use of 6% Hetastarch in 0.9% Sodium Chloride Injection in leukapheresis has also been shown to be safe and efficacious in improving the harvesting and increasing the yield of granulocytes by centrifugal means.